Massachusetts 2025-2026 Regular Session

Massachusetts House Bill H2503

Introduced
2/27/25  

Caption

To reduce the risks associated with allergic reactions

Impact

One major aspect of HB 2503 is the provision that businesses offering epinephrine auto-injectors are shielded from liability, barring cases of gross negligence. This provision is intended to encourage more businesses to become involved in emergency response efforts related to severe allergic reactions. Furthermore, the bill mandates that employees or designated agents receive necessary training to safely administer epinephrine, which includes recognizing the signs of anaphylaxis and following appropriate procedures for storage and administration. This regulation aims to ensure that effective emergency care can be delivered swiftly and efficiently.

Summary

House Bill 2503, titled 'An Act to reduce the risks associated with allergic reactions,' aims to enhance public safety by allowing businesses and other entities to possess and administer epinephrine auto-injectors. The legislation directs the Department of Public Health to create regulations that enable employees of these businesses to provide immediate access to epinephrine for individuals who may be experiencing anaphylaxis symptoms, regardless of their prior prescription status. This bill is focused on creating safer environments in public spaces and increasing the responsiveness to allergic reactions.

Contention

Despite its intended benefits, HB 2503 has generated some discussions and potential contention around its implementation. Proponents argue that the bill enhances safety in public and business environments where allergic reactions may occur, which could lead to significant life-saving interventions. However, critics might raise concerns about the implications of liability waivers and the adequacy of training for employees, questioning whether businesses can properly manage the risks associated with administering medication without medical oversight. The long-term effectiveness of such initiatives will depend on the successful rollout of the proposed regulations and training programs.

Companion Bills

MA H4607

Replaced by Relative to increasing access to epinephrine

Previously Filed As

MA S1478

To reduce the risks associated with allergic reactions

MA S08587

Requires child day care centers to have epinephrine devices and staff trained to use them on site in case of anaphylaxis or other severe allergic reaction.

MA A09245

Requires child day care centers to have epinephrine devices and staff trained to use them on site in case of anaphylaxis or other severe allergic reaction.

MA HR0126

A resolution to urge the United States Armed Forces to expand the use of medical waivers for recruits with food allergies, including allergies to peanuts.

MA H4607

Relative to increasing access to epinephrine

MA HB2047

Schools; creating the Emerson Kate Cole Act; school medication policies; eliminating references to epinephrine injectors; eliminating reference to certain training program; parent permissions; 911; mandating parent notifications; allergic reactions; model policies; annual training.

MA HB2047

Schools; creating the Emerson Kate Cole Act; school medication policies; eliminating references to epinephrine injectors; eliminating reference to certain training program; parent permissions; 911; mandating parent notifications; allergic reactions; model policies; annual training.

MA SB783

Requires child care facilities to adopt allergy policies

MA SB1260

Requires child care facilities to adopt allergy policies

MA HB2365

Establishes provisions relating to allergy prevention and responses in child care facilities

Similar Bills

MS SB2197

Epinephrine auto-injectors; allow certain entities to stock and provide or administer during anaphylactic emergencies.

NH HB63

Relative to the use of nasal spray to treat anaphylaxis.

NH HB677

Relative to the possession and use of epinephrine at recreation camps, schools, and institutions of higher education.

IL HB2462

DILLON’S LAW

PA HB1044

In epinephrine auto-injector entities, further providing for scope of chapter, for definitions and for epinephrine auto-injectors for authorized entities; and making an editorial change.

MA S817

To ensure access to epinephrine for minors

NJ A3655

Extends "Epinephrine Access and Emergency Treatment Act" to include administration of epinephrine auto-injector devices by individuals in possession of devices pursuant to personal prescriptions.

MO SB783

Requires child care facilities to adopt allergy policies